Filter
58
Filtered Results: 58
Text search:
Chagas
Coalition
Featured
Recommendations
7
New Publications
13
Language
Document type
Studies & Reports
16
No document type
16
Strategic & Response Plan
7
Resource Platforms
6
Guidelines
5
Manuals
3
Training Material
1
Brochures
1
App
1
Videos
1
Fact sheets
1
Countries / Regions
Global
7
Venezuela
3
Latin America and the Carribbean
2
Ghana
1
Africa
1
Western and Central Europe
1
Paraguay
1
Bolivia
1
Brazil
1
Authors & Publishers
Publication Years
Category
Countries
7
Clinical Guidelines
5
Key Resources
4
Public Health
2
Women & Child Health
1
Toolboxes
NTDs
28
HIV
5
NCDs
3
Rapid Response
2
COVID-19
2
Planetary Health
2
Refugee
1
Ebola & Marburg
1
Pharmacy
1
Health Financing Toolbox
1
Global Health Education
1
Chagas Coalition Resource Platform
recommended
Global chagas coalitions members contributions
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
Chagas disease, which is caused by infection with the parasite Trypanosoma cruzi, is known as the silent disease. An estimated 8 million people have the disease and most of them do not know that they are infected.
It is estimated that, in Latin America alone, between 6 and 8 million people are infected with the parasite, and 99% of these are not receiving treatment, either because they are unaware of their infection or because they do not know that treatment exists. The potential spread of the disease is also...
Info Chagas
What do we need to know abaout Chagas Disease? What is Chagas Disease?
Causada por el parásito Trypanosoma cruzi, la enfermedad de Chagas es una enfermedad silenciosa. Se estima que 8 millones de personas son portadoras y la mayoría no lo sabe.
This is a tool meant to share and train the healthcare workers with precise and updated information about Chagas disease, in order to increase the amount of diagnostics and treatments amongst the affected people.
La enfermedad de Chagas es originaria de Sudamérica, Centroamérica y México, regiones donde se estima que hay cerca de 8 millones de afectados y 20.000 muertes anuales.
Website available in Englisch and Spnish
Cursos online y Actualización Profesional: Para mejorar el acceso a la atención integral de la enfermedad de Chagas
Guía de Líderes comunitaros
Glob Heart . 2020 Oct 13;15(1):69. doi: 10.5334/gh.891.
Bolivia 2016
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e220083chgsa, 2022
Two adjectives raise an issue for communicators working on Chagas disease (CD): “invisible and silent”. Two adjectives that can be ascribed to other neglected tropical diseases (NTD), but which are part of the essence of CD. Br...
Apuntes del Taller, Anexo
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
The objective of the EMTCT Plus initiative is to achieve and sustain the elimination
of mother-to-child transmission of HIV, syphilis, Chagas, and perinatal hepatitis
B (HBV) as a public health threat. It embraces the principles and lines of action
of the Strategy for Universal Access to Health a...
Informe Conjunto de Organizaciones de Defensa del Derecho a la Salud al Comité de Derechos Económicos y Sociales de las Naciones Unidas, con motivo del Examen del 3er Informe Periódico del Estado Venezolano en el Período de Sesión 55° del Pacto Internacional de Derechos Económicos, Sociales y...
Robust clinical research capacity in low- and middle-income countries is key to stemming the spread of epidemics, according to a new report from the International Vaccines Task Force (IVTF). The report lays out how to develop the political support, financing and coordination required to build this c...
